Cited by 19

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Characterization of selective exosomal microRNA expression profile derived from laryngeal squamous cell carcinoma detected by next generation sequencing

Huang, Qiang, Yang, Jiechao, Zheng, Juan, Hsueh, Chiyao, Guo, Yang, Zhou, Liang·2018·Oncology Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/or.2018.6672

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Characterization of exosomes. (A) Electron microscopy of exosomes derived from the LSCC cell line AMC-HN-8. The image revealed membrane-bound particles that were homogeneous in appearance and ranged from 30–150 nm in size. Scale bar, 200 nm. (B) The diagram revealed the size distribution of exosomes by means of NTA. Error bars indicated +/-1 standard error of the mean. (C) Representative images of flow cytometry. Exosomes derived from the LSCC cell line AMC-HN-8 were stained with anti-CD63 and anti-CD81 immunofluorescence antibodies and analyzed by flow cytometry. Values indicate the ratio of positive exosomes. LSCC, laryngeal squamous cell carcinoma; NTA, nanoparticle tracking analysis.
Figure 1. Characterization of exosomes. (A) Electron microscopy of exosomes derived from the LSCC cell line AMC-HN-8. The image revealed membrane-bound particles that were homogeneous in appearance and ranged from 30–150 nm in size. Scale bar, 200 nm. (B) The diagram revealed the size distribution of exosomes by means of NTA. Error bars indicated +/-1 standard error of the mean. (C) Representative images of flow cytometry. Exosomes derived from the LSCC cell line AMC-HN-8 were stained with anti-CD63 and anti-CD81 immunofluorescence antibodies and analyzed by flow cytometry. Values indicate the ratio of positive exosomes. LSCC, laryngeal squamous cell carcinoma; NTA, nanoparticle tracking analysis.CC BY-NC-ND · PubMed Central
Figure 2. Comparison of total reads annotation in the cells and exosomes derived from LSCC cell line AMC-HN-8. (A) The total RNA read sequences in the cells and exosomes, revealed the annotation of ncRNA. The percentage is calculated as a percentage of clean reads. (B) The common reads of total RNA for cells and exosomes only accounted for 5.63%. (C) The diagram displayed the top 10 miRNAs in cells and exosomes, respectively. LSCC, laryngeal squamous cell carcinoma.
Figure 2. Comparison of total reads annotation in the cells and exosomes derived from LSCC cell line AMC-HN-8. (A) The total RNA read sequences in the cells and exosomes, revealed the annotation of ncRNA. The percentage is calculated as a percentage of clean reads. (B) The common reads of total RNA for cells and exosomes only accounted for 5.63%. (C) The diagram displayed the top 10 miRNAs in cells and exosomes, respectively. LSCC, laryngeal squamous cell carcinoma.CC BY-NC-ND · PubMed Central
Figure 3. The different microRNA expression profiles between parental cells and exosomes. (A) The heat map revealed the distinct miRNA expression profiles between parental cells and exosomes. The inclusion criteria was a 2-fold difference of log2 (fold-change) in either direction with a P-value <0.05. Red signal, high relative expression; green signal, low relative expression. (B) The volcano plot revealed the marked expression of miRNAs in exosomes. The inclusion criteria was a 2-fold difference of log2 (fold-change) in either direction with a P-value <0.05. Red, upregulated in the exosomes; green, downregulated in the exosomes.
Figure 3. The different microRNA expression profiles between parental cells and exosomes. (A) The heat map revealed the distinct miRNA expression profiles between parental cells and exosomes. The inclusion criteria was a 2-fold difference of log2 (fold-change) in either direction with a P-value <0.05. Red signal, high relative expression; green signal, low relative expression. (B) The volcano plot revealed the marked expression of miRNAs in exosomes. The inclusion criteria was a 2-fold difference of log2 (fold-change) in either direction with a P-value <0.05. Red, upregulated in the exosomes; green, downregulated in the exosomes.CC BY-NC-ND · PubMed Central
Figure 4. RT-qPCR validation. RT-qPCR was used to validate the results of small RNA sequencing. Six miRNAs accepted in the analysis (miR-320d, miR-1246, miR-122-5p, miR-4483, miR-30c-5p and let-7e-5p) were selected randomly. (A) LSCC cell line AMC-HN-8. (B) LSCC cell line Tu212. (C) LSCC cell line Tu686. The obtained values were normalized to hsa-miR-93-5p used as an internal control. Black, RNA-sequencing; Grey, RT-qPCR. RT-qPCR, reverse transcription quantitative PCR; LSCC, laryngeal squamous cell carcinoma.
Figure 4. RT-qPCR validation. RT-qPCR was used to validate the results of small RNA sequencing. Six miRNAs accepted in the analysis (miR-320d, miR-1246, miR-122-5p, miR-4483, miR-30c-5p and let-7e-5p) were selected randomly. (A) LSCC cell line AMC-HN-8. (B) LSCC cell line Tu212. (C) LSCC cell line Tu686. The obtained values were normalized to hsa-miR-93-5p used as an internal control. Black, RNA-sequencing; Grey, RT-qPCR. RT-qPCR, reverse transcription quantitative PCR; LSCC, laryngeal squamous cell carcinoma.CC BY-NC-ND · PubMed Central
Figure 5. Bioinformatics analysis of potential targets of selective exosomal miRNAs. (A) GO annotation of predicted targets. (B) KEGG pathway enrichment analysis of predicted targets. GO terms and KEGG pathway both with a P-value <0.05 were selected. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.
Figure 5. Bioinformatics analysis of potential targets of selective exosomal miRNAs. (A) GO annotation of predicted targets. (B) KEGG pathway enrichment analysis of predicted targets. GO terms and KEGG pathway both with a P-value <0.05 were selected. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.CC BY-NC-ND · PubMed Central
Figure 6. Selective exosomal miRNA-gene co-expression network. (A) The network revealed the interactions between exosomal miRNAs and genes. Blue, miRNAs; Pink, genes. (B) The most common overlap of genes.
Figure 6. Selective exosomal miRNA-gene co-expression network. (A) The network revealed the interactions between exosomal miRNAs and genes. Blue, miRNAs; Pink, genes. (B) The most common overlap of genes.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 33

  1. [1]Steuer CE El-Deiry M Parks JR Higgins KA Saba NF An update on larynx cancer CA Cancer J Clin 67 31 50 2017 10.3322/caac.21386 27898173 · DOI
  2. [2]Siegel RL Miller KD Jemal A Cancer statistics, 2016 CA Cancer J Clin 66 7 30 2016 10.3322/caac.21332 26742998 · DOI · Paper page
  3. [3]Foekens JA Sieuwerts AM Smid M Look MP de Weerd V Boersma AW Klijn JG Wiemer EA Martens JW Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer Proc Natl Acad Sci USA 105 13021 13026 2008 10.1073/pnas.0803304105 18755890 PMC2529088 · DOI
  4. [4]Kelly EJ Hadac EM Greiner S Russell SJ Engineering microRNA responsiveness to decrease virus pathogenicity Nat Med 14 1278 1283 2008 10.1038/nm.1776 18953352 · DOI
  5. [5]Ji J Shi J Budhu A Yu Z Forgues M Roessler S Ambs S Chen Y Meltzer PS Croce CM MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 1437 1447 2009 10.1056/NEJMoa0901282 19812400 PMC2786938 · DOI
  6. [6]Cao P Zhou L Zhang J Zheng F Wang H Ma D Tian J Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma Head Neck 35 720 728 2013 10.1002/hed.23011 22605671 · DOI
  7. [7]Hui AB Lenarduzzi M Krushel T Waldron L Pintilie M Shi W Perez-Ordonez B Jurisica I O'Sullivan B Waldron J Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas Clin Cancer Res 16 1129 1139 2010 10.1158/1078-0432.CCR-09-2166 20145181 · DOI
  8. [8]Tkach M Théry C Communication by extracellular vesicles: Where we are and where we need to go Cell 164 1226 1232 2016 10.1016/j.cell.2016.01.043 26967288 · DOI · Paper page
  9. [9]Van Niel G D'Angelo G Raposo G Shedding light on the cell biology of extracellular vesicles Nat Rev Mol Cell Biol 19 213 228 2018 10.1038/nrm.2017.125 29339798 · DOI · Paper page
  10. [10]Valadi H Ekström K Bossios A Sjöstrand M Lee JJ Lötvall JO Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 654 659 2007 10.1038/ncb1596 17486113 · DOI · Paper page
  11. [11]Ye SB Zhang H Cai TT Liu YN Ni JJ He J Peng JY Chen QY Mo HY Jun-Cui Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma J Pathol 240 329 340 2016 10.1002/path.4781 27538493 · DOI
  12. [12]Li L Li C Wang S Wang Z Jiang J Wang W Li X Chen J Liu K Li C Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype Cancer Res 76 1770 1780 2016 10.1158/0008-5472.CAN-15-1625 26992424 · DOI
  13. [13]Wang J Zhou Y Lu J Sun Y Xiao H Liu M Tian L Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma Med Oncol 31 148 2014 10.1007/s12032-014-0148-8 25099764 · DOI
  14. [14]Kogure T Lin WL Yan IK Braconi C Patel T Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth Hepatology 54 1237 1248 2011 10.1002/hep.24504 21721029 PMC3310362 · DOI · Paper page
  15. [15]Dickman CT Lawson J Jabalee J MacLellan SA LePard NE Bennewith KL Garnis C Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes Oncotarget 8 15252 15266 2017 10.18632/oncotarget.14862 28146434 PMC5362484 · DOI
  16. [16]Lawson J Dickman C MacLellan S Towle R Jabalee J Lam S Garnis C Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells Oncotarget 8 83913 83924 2017 10.18632/oncotarget.19996 29137392 PMC5663564 · DOI
  17. [17]Honegger A Schilling D Bastian S Sponagel J Kuryshev V Sültmann H Scheffner M Hoppe-Seyler K Hoppe-Seyler F Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells PLoS Pathog 11 e1004712 2015 10.1371/journal.ppat.1004712 25760330 PMC4356518 · DOI · Paper page
  18. [18]Kim SY Chu KC Lee HR Lee KS Carey TE Establishment and characterization of nine new head and neck cancer cell lines Acta Otolaryngol 117 775 784 1997 10.3109/00016489709113477 9349880 · DOI
  19. [19]Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method Methods 25 402 408 2001 10.1006/meth.2001.1262 11846609 · DOI · Paper page
  20. [20]Matsuzaki K Fujita K Jingushi K Kawashima A Ujike T Nagahara A Ueda Y Tanigawa G Yoshioka I Ueda K MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma Oncotarget 8 24668 24678 2017 10.18632/oncotarget.14969 28160564 PMC5421878 · DOI
  21. [21]Park SK Park YS Ahn JY Do EJ Kim D Kim JE Jung K Byeon JS Ye BD Yang DH MiR 21-5p as a predictor of recurrence in young gastric cancer patients J Gastroenterol Hepatol 31 1429 1435 2016 10.1111/jgh.13300 26824898 · DOI
  22. [23]Hannafon BN Trigoso YD Calloway CL Zhao YD Lum DH Welm AL Zhao ZJ Blick KE Dooley WC Ding WQ Plasma exosome microRNAs are indicative of breast cancer Breast Cancer Res 18 90 2016 10.1186/s13058-016-0753-x 27608715 PMC5016889 · DOI
  23. [25]Yoo NJ Hur SY Kim MS Lee JY Lee SH Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers APMIS 118 271 276 2010 10.1111/j.1600-0463.2010.02588.x 20402672 · DOI
  24. [26]Pan BT Teng K Wu C Adam M Johnstone RM Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes J Cell Biol 101 942 948 1985 10.1083/jcb.101.3.942 2993317 PMC2113705 · DOI
  25. [28]Becker A Thakur BK Weiss JM Kim HS Peinado H Lyden D Extracellular vesicles in cancer: Cell-to-Cell mediators of metastasis Cancer Cell 30 836 848 2016 10.1016/j.ccell.2016.10.009 27960084 PMC5157696 · DOI · Paper page
  26. [29]Guo H Ingolia NT Weissman JS Bartel DP Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 466 835 840 2010 10.1038/nature09267 20703300 PMC2990499 · DOI · Paper page
  27. [30]Baglio SR Rooijers K Koppers-Lalic D Verweij FJ Pérez Lanzón M Zini N Naaijkens B Perut F Niessen HW Baldini N Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species Stem Cell Res Ther 6 127 2015 10.1186/s13287-015-0116-z 26129847 PMC4529699 · DOI
  28. [31]Endzeliņš E Berger A Melne V Bajo-Santos C Soboļevska K Ābols A Rodriguez M Šantare D Rudņickiha A Lietuvietis V Detection of circulating miRNAs: Comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients BMC Cancer 17 730 2017 10.1186/s12885-017-3737-z 29121858 PMC5679326 · DOI
  29. [32]Chen J Yu Y Li S Liu Y Zhou S Cao S Yin J Li G MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy J Cell Mol Med 21 3679 3692 2017 10.1111/jcmm.13278 28766848 PMC5706581 · DOI
  30. [33]Théry C Amigorena S Raposo G Clayton A Isolation and characterization of exosomes from cell culture supernatants and biological fluids Curr Protoc Cell Biol Chapter 3 Unit 3.22 2006 18228490
  31. [34]Yao XD Li P Wang JS MicroRNA differential expression spectrum and microRNA-125a-5p inhibition of laryngeal cancer cell proliferation Exp Ther Med 14 1699 1705 2017 10.3892/etm.2017.4685 28810638 PMC5525897 · DOI
  32. [35]Hummel R Sie C Watson DI Wang T Ansar A Michael MZ Van der Hoek M Haier J Hussey DJ MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines World J Gastroenterol 20 14904 14912 2014 10.3748/wjg.v20.i40.14904 25356050 PMC4209553 · DOI
  33. [36]Xu YF Hannafon BN Zhao YD Postier RG Ding WQ Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer Oncotarget 8 77028 77040 2017 29100367 PMC5652761

Cited by

Sorted by citations

Metadata

Authors
Huang, Q., Yang, J., Zheng, J., Hsueh, C., Guo, Y., & Zhou, L.
Affiliations
Department of Otorhinolaryngology Head and Neck Surgery, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai 200031, P.R.�China
Venue
Oncology Reports
Published
2018-08-24
ISSN
  • 1021-335X
  • 1791-2431
Cited by
19
References
3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review